Diclofenac/lidocaine - Yung ShinAlternative Names: Topical VDO; VDO
Latest Information Update: 25 Apr 2016
At a glance
- Originator Yung Shin Pharmaceutical
- Mechanism of Action Cyclophilin inhibitors; Sodium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Herpes labialis
Most Recent Events
- 01 Jul 2014 Phase-II clinical trials in Herpes labialis in Taiwan (Topical)